Myeloma is a cancer of the plasma cells of the blood. Symptoms include early osteoporosis, hypercalcemia, hyperviscosity of the blood, low red and white blood cell counts, low platelet count, cryoglobulinemia, and amyloidosis. Tests to diagnose multiple
Anetor JI,Ajose FI,Akingbola TS. A case of IgA multiple myeloma:Nutritional perspective in diagnostic testing[J].Indian J Clin Biochem,2005,(01):193-197.doi:10.1007/BF02893069.Anetor JI,Ajose FI,Akingbola TS. A case of IgA multiple myeloma:Nutritional perspective in diagnostic testing[J]...
EP: 1.Multiple Myeloma: Challenges in Diagnosis and Role of Multidisciplinary Care Now Viewing EP: 2.Educating on Multiple Myeloma: Patient and Physician Resources EP: 3.Role of Diagnostic Testing in Patients with Multiple Myeloma EP: 4.Treatment Considerations for Patients with Newly Diagnosed...
Multiple myeloma (MM) is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell lines.[1]MM is part of a spectrum of diseases rangi...
EP: 4.MRD Testing in Multiple Myeloma EP: 5.Managing Adequate/Inadequate Treatment Response in MM EP: 6.Managing A Case of Newly-Diagnosed Transplant-Ineligible MM EP: 7.Triplet Vs Doublet Therapy for Transplant-Ineligible MM EP: 8.Maintenance Therapy for Transplant-Ineligible MM ...
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.
“This presentation comes on the heels of our successful presentation at ASCO, where the final validation of TeloView test for SMM patients was recently presented. These data confirm the broad applicability of the TeloView platform and the expanded potential of our pip...
Multiple myelomaThe classic presentation of multiple myeloma is bone pain, often involving the back and ribs. In the case described here, however, the patient had severe, incapacitating arthralgias. Dr Goodman and Dr Libanati detail how they arrived at the correct diagnosis....
In an interview with Targeted Oncology, Jens Hillengass, MD, shared his insights on the latest edition of the diagnostic and staging criteria for multiple myeloma that have become standard now for the management of these patients. Jens Hillengass, MD Due to a dramatic paradigm shift in multiple...
6 Diagnostic criteria for SMM are 10–59% clonal plasma cells in the bone marrow and/or M protein at myeloma levels, with an absence of myeloma-defining events. Plasmacytomas, which are single localized tumors of monoclonal plasma cells, are also capable of producing an M spike. ...